Literature DB >> 18278558

Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease.

Michael Teitcher1, Sarah Weinerman, Catharina Whybra, Michael Beck, Nir Sharon, Deborah Elstein, Gheona Altarescu.   

Abstract

Fabry disease, an X-linked inborn error of metabolism, is characterized by multi-organ involvement including cardiac signs of left ventricular hypertrophy and abnormal intima-medial (IMT) thickening of arteries, progressive renal failure, neurological involvement, and more. The vitamin D receptor (VDR) and an enzyme producing vitamin D3 result in an autocrine loop with direct effects on blood vessels. The purpose of this study is to assess VDR polymorphisms (BsmI, FokI, ApaI, and TaqI) relative to clinically important disease parameters using a disease-specific severity score (MSSI) and haplotype analysis. There were statistically significant differences between females (43% of 74 patients) and males in MSSI total scores, and in general and neurologic sub-scores. There appears to be a protective effect of the TaqI tt genotype so that there were significantly lower scores in clinical categories between those with the tt genotype versus those with the TT genotype. Multivariate models of haplotypes with MSSI scores reveal that T-A-f-B and t-a-F-b haplotypes of the VDR gene polymorphisms are significantly associated with variation in the Fabry phenotype. Despite the limitations of using the MSSI score as a clinical correlate, these results are provocative and further studies in larger cohorts with more males are recommended.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278558     DOI: 10.1007/s10709-008-9245-y

Source DB:  PubMed          Journal:  Genetica        ISSN: 0016-6707            Impact factor:   1.082


  37 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Disease manifestations and X inactivation in heterozygous females with Fabry disease.

Authors:  Esther M Maier; Stephanie Osterrieder; Catharina Whybra; Markus Ries; Andreas Gal; Michael Beck; Adelbert A Roscher; Ania C Muntau
Journal:  Acta Paediatr Suppl       Date:  2006-04

3.  Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease.

Authors:  Frédéric Barbey; Noureddine Brakch; Ales Linhart; Xavier Jeanrenaud; Thomas Palecek; Jan Bultas; Michel Burnier; Daniel Hayoz
Journal:  Acta Paediatr Suppl       Date:  2006-04

4.  Bone mineral density and bone markers in relation to vitamin D receptor gene polymorphisms in Chinese men and women.

Authors:  K S Tsai; S H Hsu; W C Cheng; C K Chen; P U Chieng; W H Pan
Journal:  Bone       Date:  1996-11       Impact factor: 4.398

Review 5.  Advances in the treatment of inherited metabolic diseases.

Authors:  R J Desnick; G A Grabowski
Journal:  Adv Hum Genet       Date:  1981

6.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

Authors:  R O Brady; A E Gal; R M Bradley; E Martensson; A L Warshaw; L Laster
Journal:  N Engl J Med       Date:  1967-05-25       Impact factor: 91.245

7.  An association study of inflammatory cytokine gene polymorphisms in Fabry disease.

Authors:  Rachael Safyan; Catharina Whybra; Michael Beck; Deborah Elstein; Gheona Altarescu
Journal:  Eur Cytokine Netw       Date:  2006-12       Impact factor: 2.737

8.  An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

Authors:  S Nakao; T Takenaka; M Maeda; C Kodama; A Tanaka; M Tahara; A Yoshida; M Kuriyama; H Hayashibe; H Sakuraba
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

9.  Arterial remodelling in Fabry disease.

Authors:  P Boutouyrie; S Laurent; B Laloux; O Lidove; J P Grunfeld; D P Germain
Journal:  Acta Paediatr Suppl       Date:  2002

10.  Enhancement of vasoconstrictor response by a noncalcemic analogue of vitamin D3.

Authors:  T Shimosawa; K Ando; T Fujita
Journal:  Hypertension       Date:  1993-02       Impact factor: 10.190

View more
  4 in total

1.  Fabry disease and early stroke.

Authors:  U Feldt-Rasmussen
Journal:  Stroke Res Treat       Date:  2011-06-23

Review 2.  The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations.

Authors:  Valentina Citro; Marco Cammisa; Ludovica Liguori; Chiara Cimmaruta; Jan Lukas; Maria Vittoria Cubellis; Giuseppina Andreotti
Journal:  Int J Mol Sci       Date:  2016-12-01       Impact factor: 5.923

3.  Vitamin D receptor gene polymorphism predicts left ventricular hypertrophy in maintenance hemodialysis.

Authors:  Bingman Liu; Qingqing Yang; Liangyu Zhao; Hua Shui; Xiaoyun Si
Journal:  BMC Nephrol       Date:  2022-01-15       Impact factor: 2.388

Review 4.  Anderson-Fabry disease in heart failure.

Authors:  M M Akhtar; P M Elliott
Journal:  Biophys Rev       Date:  2018-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.